TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Potential implications of mesenchymal stem cells in cancer therapy

(2011) Long-Jun Dai et al.   CANCER LETTERS

In vitro effects of an in silico-modelled 17β-estradiol derivative in combination with dichloroacetic acid on MCF-7 and MCF-12A cells

(2011) X. X. Stander et al.   CELL PROLIFERATION

Impedance measurement for real time detection of neuronal cell death

(2011) S. Diemert et al.   JOURNAL OF NEUROSCIENCE METHODS

HIV Infection Enhances TRAIL-Induced Cell Death in Macrophage by Down-Regulating Decoy Receptor Expression and Generation of Reactive Oxygen Species

(2011) Dan-Ming Zhu et al.   PLoS One

Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine

(2011) Xu-Yong Sun   World Journal of Stem Cells

TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo

(2010) L P Mueller et al.   CANCER GENE THERAPY

TRAIL-Induced Apoptosis Is Preferentially Mediated via TRAIL Receptor 1 in Pancreatic Carcinoma Cells and Profoundly Enhanced by XIAP Inhibitors

(2010) D. Stadel et al.   CLINICAL CANCER RESEARCH

Mesenchymal stromal cells alone or expressing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment

(2010) Shannon Kidd et al.   CYTOTHERAPY

Mesenchymal Stem Cells Protect Breast Cancer Cells through Regulatory T Cells: Role of Mesenchymal Stem Cell-Derived TGF- 

(2010) S. A. Patel et al.   JOURNAL OF IMMUNOLOGY

TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5

(2010) Johannes Lemke et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell-Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma Cells

(2010) Andrea Mohr et al.   STEM CELLS

Targeting Tumor Stroma Using Engineered Mesenchymal Stem Cells Reduces the Growth of Pancreatic Carcinoma

(2009) Christoph Zischek et al.   ANNALS OF SURGERY

TRAIL as a target in anti-cancer therapy

(2009) Gen Sheng Wu   CANCER LETTERS

Magnetic Resonance Imaging of Mesenchymal Stem Cells Homing to Pulmonary Metastases Using Biocompatible Magnetic Nanoparticles

(2009) M. R. Loebinger et al.   CANCER RESEARCH

Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence

(2009) Jana Luetzkendorf et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

DUAL-TARGETED ANTITUMOR EFFECTS AGAINST BRAINSTEM GLIOMA BY INTRAVENOUS DELIVERY OF TUMOR NECROSIS FACTOR-RELATED, APOPTOSIS-INDUCING, LIGAND-ENGINEERED HUMAN MESENCHYMAL STEM CELLS

(2009) Bojie Yang et al.   NEUROSURGERY

High TRAIL Death Receptor 4 and Decoy Receptor 2 Expression Correlates With Significant Cell Death in Pancreatic Ductal Adenocarcinoma Patients

(2009) Ahter Dilsad Sanlioglu et al.   PANCREAS

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

(2009) L. S. Sasportas et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging

(2009) Shannon Kidd et al.   STEM CELLS

Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model

(2008) Ling Qiao et al.   CELL RESEARCH

A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury

(2008) Z.-X. Zhang et al.   CYTOTHERAPY

Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma

(2008) Adam M. Sonabend et al.   STEM CELLS